During the last session, I-Mab ADR (NASDAQ:IMAB)’s traded shares were 0.52 million, with the beta value of the company hitting 1.16. At the end of the trading day, the stock’s price was $1.31, reflecting an intraday gain of 3.97% or $0.05. The 52-week high for the IMAB share is $2.00, that puts it down -52.67 from that peak though still a striking 54.2% gain since the share price plummeted to a 52-week low of $0.60. The company’s market capitalization is $103.41M, and the average trade volume was 227.34K shares over the past three months.

I-Mab ADR (IMAB) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. IMAB has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it.

I-Mab ADR (NASDAQ:IMAB) trade information

I-Mab ADR (IMAB) registered a 3.97% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 3.97% in intraday trading to $1.31, hitting a weekly high. The stock’s 5-day price performance is 24.76%, and it has moved by 39.36% in 30 days. Based on these gigs, the overall price performance for the year is -24.71%.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 28.36%. While earnings are projected to return -31.25% in 2025.

IMAB Dividends

I-Mab ADR is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

The next largest institutional holding, with 3.37 million shares, is of CALIGAN PARTNERS LP’s that is approximately 3.8067% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $5.64 million.

Also, the Mutual Funds coming in first place with the largest holdings of I-Mab ADR (IMAB) shares are abrdn Healthcare Investors and abrdn Healthcare Opportunities Fund . Data provided on Dec 31, 2024 indicates that abrdn Healthcare Investors owns about 53.88 shares. This amounts to just over 0.07 percent of the company’s overall shares, with a $70589.0 market value. The same data shows that the other fund manager holds slightly less at 43.74, or about 0.05% of the stock, which is worth about $57296.0.